HRP20080023T3 - Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof - Google Patents

Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof

Info

Publication number: HRP20080023T3
Authority: HR; Croatia
Prior art keywords: alkyl; phenyl; alkenyl; alkylene; replaced
Prior art date: 2004-06-11

Application number

HR20080023T

Other languages

English (en)

Croatian (hr)

Inventor

Brummerhop Harm

Frick Wendelin

Glombik Heiner

Plettenburg Oliver

Bickel Martin

Heuer Hubert

Theis Stefan

Original Assignee

Sanofi-Aventis Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-11

Filing date

2005-06-03

Publication date

2008-06-30

2005-06-03 Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh

2008-06-30 Publication of HRP20080023T3 publication Critical patent/HRP20080023T3/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Child & Adolescent Psychology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)

HR20080023T 2004-06-11 2005-06-03 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof HRP20080023T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004028241A DE102004028241B4 (de)	2004-06-11	2004-06-11	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
PCT/EP2005/005959 WO2005121161A1 (fr)	2004-06-11	2005-06-03	Nouveaux derives fluoroglycosidiques de pyrazoles, medicaments contenant ces composes et leur utilisation

Publications (1)

Publication Number	Publication Date
HRP20080023T3 true HRP20080023T3 (en)	2008-06-30

Family

ID=35355753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20080023T HRP20080023T3 (en)	2004-06-11	2005-06-03	Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof

Country Status (33)

Country	Link
US (1)	US7820804B2 (fr)
EP (1)	EP1758914B1 (fr)
JP (1)	JP4996464B2 (fr)
CN (1)	CN100582116C (fr)
AR (1)	AR049393A1 (fr)
AU (1)	AU2005252329B2 (fr)
BR (1)	BRPI0510770A (fr)
CA (1)	CA2570042C (fr)
CR (1)	CR8773A (fr)
CY (1)	CY1107426T1 (fr)
DE (2)	DE102004028241B4 (fr)
DK (1)	DK1758914T3 (fr)
EC (1)	ECSP067054A (fr)
ES (1)	ES2296180T3 (fr)
HR (1)	HRP20080023T3 (fr)
IL (1)	IL179757A (fr)
MA (1)	MA28653B1 (fr)
MX (1)	MXPA06013513A (fr)
MY (1)	MY143565A (fr)
NO (1)	NO20070176L (fr)
NZ (1)	NZ551948A (fr)
PE (1)	PE20060297A1 (fr)
PL (1)	PL1758914T3 (fr)
PT (1)	PT1758914E (fr)
RS (1)	RS50541B (fr)
RU (1)	RU2370499C2 (fr)
SI (1)	SI1758914T1 (fr)
TN (1)	TNSN06409A1 (fr)
TW (1)	TWI382030B (fr)
UA (1)	UA89787C2 (fr)
UY (1)	UY28955A1 (fr)
WO (1)	WO2005121161A1 (fr)
ZA (1)	ZA200608832B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
DE102005026762A1 (de)	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
TW200812995A (en)	2006-05-19	2008-03-16	Taisho Pharmaceutical Co Ltd	C-phenyl glycitol compound
CA2655937A1 (fr) *	2006-06-29	2008-01-03	Taisho Pharmaceutical Co., Ltd.	Compose de c-phenyl-1-thioglucitol
BRPI0715160A2 (pt)	2006-08-08	2013-06-11	Sanofi Aventis	imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
DE102006053637B4 (de) *	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2008072726A1 (fr)	2006-12-14	2008-06-19	Taisho Pharmaceutical Co., Ltd.	Dérivé de 1-phényl 1-thio-d-glucitol
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
JP5272395B2 (ja) *	2007-12-12	2013-08-28	セントラル硝子株式会社	４−デオキシ−４−フルオロ−ｄ−グルコース誘導体の製造方法
WO2010003624A2 (fr)	2008-07-09	2010-01-14	Sanofi-Aventis	Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation
MX2011002166A (es) *	2008-08-28	2011-04-07	Pfizer	Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
WO2010068601A1 (fr)	2008-12-08	2010-06-17	Sanofi-Aventis	Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
CA2752212C (fr)	2009-02-23	2016-08-16	Taisho Pharmaceutical Co., Ltd.	Composes de 4-isopropylphenyl glucitol comme inhibiteurs de sglt1
EP2298782A1 (fr)	2009-08-26	2011-03-23	Sanofi-Aventis	Procédé de synthèse de dérivé de type pyrazole glucoside
DK2470552T3 (en)	2009-08-26	2014-02-17	Sanofi Sa	NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
MX2012003400A (es) *	2009-10-02	2012-04-10	Sanofi Sa	Uso de compuestos con actividad inhibidora de sglt - 1/sglt - 2 para producir medicamentos para el tratamiento de enfermedades oseas.
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
NZ599945A (en)	2009-11-02	2014-05-30	Pfizer	Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
CN104825417A (zh)	2009-11-13	2015-08-12	阿斯利康(瑞典)有限公司	立即释放片剂
MX2012005425A (es)	2009-11-13	2012-06-14	Astrazeneca Uk Ltd	Formulaciones de metformina de masa reducida.
ES2689107T3 (es)	2009-11-13	2018-11-08	Astrazeneca Ab	Formulaciones de tabletas bicapa
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
CA2807755A1 (fr)	2010-08-20	2012-02-23	Taisho Pharmaceutical Co., Ltd.	Forme cristalline d'un compose 4-isopropylphenyl glucitol et son procede de fabrication
US9161945B2 (en)	2010-08-20	2015-10-20	Taisho Pharmaceutical Co., Ltd.	4-isopropyl-6-methoxyphenyl glucitol compound
AU2011295837B2 (en)	2010-09-03	2015-06-18	Astrazeneca Uk Limited	Drug formulations using water soluble antioxidants
EP2670397B1 (fr)	2011-02-01	2020-05-13	Bristol-Myers Squibb Company	Formulations pharmaceutiques comprenant un composé amine
EP2766349B1 (fr)	2011-03-08	2016-06-01	Sanofi	Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
EP2683704B1 (fr)	2011-03-08	2014-12-17	Sanofi	Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
EP2683703B1 (fr)	2011-03-08	2015-05-27	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
WO2012120056A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2012120050A1 (fr)	2011-03-08	2012-09-13	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120058A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
WO2012120054A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
US8614195B2 (en) *	2011-04-14	2013-12-24	Novartis Ag	Glycoside derivatives and uses thereof
AR087701A1 (es) *	2011-08-31	2014-04-09	Japan Tobacco Inc	Derivados de pirazol con actividad inhibidora de sglt1
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr)	2011-09-27	2013-04-04	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
UA113086C2 (xx)	2012-05-10	2016-12-12		Піразольні сполуки як інгібітори sglt1
TW201425326A (zh)	2012-10-05	2014-07-01	Lilly Co Eli	新穎脲化合物
WO2014119787A1 (fr)	2013-02-04	2014-08-07	大正製薬株式会社	Médicament à visée prophylactique ou thérapeutique pour la constipation
EP2774619B1 (fr)	2013-03-04	2016-05-18	BioActive Food GmbH	Composition pour le traitement de pathologies hyperglycémiques
AR098670A1 (es)	2013-11-08	2016-06-08	Lilly Co Eli	Inhibidor de sglt1
EP2944311A1 (fr)	2014-05-16	2015-11-18	BioActive Food GmbH	Combinaison de substances biologiques actives destinée au traitement de pathologies hypoglycémiques
AR114465A1 (es) *	2018-04-04	2020-09-09	Japan Tobacco Inc	Compuestos de pirazol sustituidos con heteroarilo y su utilización farmacéutica
AU2019318209B2 (en)	2018-08-10	2025-09-25	Diapin Therapeutics, Llc	Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
EP3886854A4 (fr)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Composés pyrrole et pyrazole et leurs procédés d'utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW406086B (en) *	1996-12-26	2000-09-21	Tanabe Seiyaku Co	Propiophenone derivatives and process for preparing the same
UA71994C2 (en) *	1999-08-31	2005-01-17	Kissei Pharmaceutical	Glucopyranosyloxypyrazole derivatives, a pharmaceutical composition containing these derivatives and intermediate compounds for the preparation thereof
PH12000002657B1 (en) *	1999-10-12	2006-02-21	Bristol Myers Squibb Co	C-aryl glucoside SGLT2 inhibitors
WO2002036602A1 (fr) *	2000-11-02	2002-05-10	Ajinomoto Co., Inc.	Nouveaux derives du pyrazole et remedes au diabete contenant ces derniers
CA2438433A1 (fr) *	2001-02-14	2002-08-22	Tularik Inc.	Gene amplifie de l'hepsine associee au cancer
US20030087843A1 (en) *	2001-09-05	2003-05-08	Washburn William N.	O-pyrazole glucoside SGLT2 inhibitors and method of use
US7375087B2 (en) *	2002-08-08	2008-05-20	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
JP2004137245A (ja) *	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja) *	2002-08-27	2011-01-05	キッセイ薬品工業株式会社	ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
CA2500873C (fr) *	2002-10-04	2012-01-17	Kissei Pharmaceutical Co., Ltd.	Derive de pyrazole, composition medicinale renfermant ce derive, utilisation medicinale de cette composition, et intermediaire entrant dans sa production
US20060035844A1 (en) *	2002-12-04	2006-02-16	Fumiaki Ito	Preventive or remedy for diseases caused by hyperglycemia
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
WO2004113359A1 (fr) *	2003-06-20	2004-12-29	Kissei Pharmaceutical Co., Ltd.	Derive de pyrazole, composition de medicaments contenant ledit derive et intermediaire de production associe

2004
- 2004-06-11 DE DE102004028241A patent/DE102004028241B4/de not_active Expired - Fee Related
2005
- 2005-06-03 PL PL05746637T patent/PL1758914T3/pl unknown
- 2005-06-03 EP EP05746637A patent/EP1758914B1/fr not_active Expired - Lifetime
- 2005-06-03 WO PCT/EP2005/005959 patent/WO2005121161A1/fr not_active Ceased
- 2005-06-03 NZ NZ551948A patent/NZ551948A/en not_active IP Right Cessation
- 2005-06-03 PT PT05746637T patent/PT1758914E/pt unknown
- 2005-06-03 CN CN200580019067A patent/CN100582116C/zh not_active Expired - Fee Related
- 2005-06-03 DE DE502005002056T patent/DE502005002056D1/de not_active Expired - Lifetime
- 2005-06-03 RS RSP-2008/0017A patent/RS50541B/sr unknown
- 2005-06-03 HR HR20080023T patent/HRP20080023T3/xx unknown
- 2005-06-03 AU AU2005252329A patent/AU2005252329B2/en not_active Ceased
- 2005-06-03 JP JP2007526254A patent/JP4996464B2/ja not_active Expired - Fee Related
- 2005-06-03 RU RU2007101154/04A patent/RU2370499C2/ru not_active IP Right Cessation
- 2005-06-03 UA UAA200700259A patent/UA89787C2/ru unknown
- 2005-06-03 MX MXPA06013513A patent/MXPA06013513A/es active IP Right Grant
- 2005-06-03 SI SI200530142T patent/SI1758914T1/sl unknown
- 2005-06-03 DK DK05746637T patent/DK1758914T3/da active
- 2005-06-03 BR BRPI0510770-9A patent/BRPI0510770A/pt not_active IP Right Cessation
- 2005-06-03 ES ES05746637T patent/ES2296180T3/es not_active Expired - Lifetime
- 2005-06-03 CA CA2570042A patent/CA2570042C/fr not_active Expired - Fee Related
- 2005-06-09 MY MYPI20052616A patent/MY143565A/en unknown
- 2005-06-09 TW TW094118973A patent/TWI382030B/zh not_active IP Right Cessation
- 2005-06-10 PE PE2005000666A patent/PE20060297A1/es not_active Application Discontinuation
- 2005-06-10 UY UY28955A patent/UY28955A1/es unknown
- 2005-06-13 AR ARP050102406A patent/AR049393A1/es not_active Application Discontinuation
2006
- 2006-10-24 ZA ZA200608832A patent/ZA200608832B/en unknown
- 2006-11-27 CR CR8773A patent/CR8773A/es not_active Application Discontinuation
- 2006-11-30 IL IL179757A patent/IL179757A/en not_active IP Right Cessation
- 2006-12-05 MA MA29515A patent/MA28653B1/fr unknown
- 2006-12-06 US US11/567,410 patent/US7820804B2/en not_active Expired - Fee Related
- 2006-12-08 TN TNP2006000409A patent/TNSN06409A1/en unknown
- 2006-12-08 EC EC2006007054A patent/ECSP067054A/es unknown
2007
- 2007-01-10 NO NO20070176A patent/NO20070176L/no not_active Application Discontinuation
2008
- 2008-02-04 CY CY20081100139T patent/CY1107426T1/el unknown

Also Published As

Publication number	Publication date
PL1758914T3 (pl)	2008-04-30
CR8773A (es)	2008-02-28
AR049393A1 (es)	2006-07-26
CN100582116C (zh)	2010-01-20
RU2370499C2 (ru)	2009-10-20
DE502005002056D1 (de)	2008-01-03
MXPA06013513A (es)	2007-03-01
AU2005252329A1 (en)	2005-12-22
CY1107426T1 (el)	2012-12-19
MY143565A (en)	2011-05-31
PT1758914E (pt)	2008-01-31
RS50541B (sr)	2010-05-07
TNSN06409A1 (en)	2008-02-22
UA89787C2 (ru)	2010-03-10
IL179757A0 (en)	2007-05-15
WO2005121161A1 (fr)	2005-12-22
DE102004028241A1 (de)	2006-01-05
TWI382030B (zh)	2013-01-11
US7820804B2 (en)	2010-10-26
RU2007101154A (ru)	2008-07-20
PE20060297A1 (es)	2006-05-25
NO20070176L (no)	2007-03-09
US20070197623A1 (en)	2007-08-23
TW200610527A (en)	2006-04-01
CA2570042C (fr)	2013-01-15
ZA200608832B (en)	2008-05-28
CN1964984A (zh)	2007-05-16
AU2005252329B2 (en)	2011-02-10
BRPI0510770A (pt)	2007-11-20
SI1758914T1 (sl)	2008-04-30
UY28955A1 (es)	2006-01-31
HK1100411A1 (zh)	2007-09-21
CA2570042A1 (fr)	2005-12-22
DK1758914T3 (da)	2008-03-17
ECSP067054A (es)	2007-01-26
JP2008501745A (ja)	2008-01-24
MA28653B1 (fr)	2007-06-01
DE102004028241B4 (de)	2007-09-13
ES2296180T3 (es)	2008-04-16
IL179757A (en)	2010-12-30
JP4996464B2 (ja)	2012-08-08
EP1758914A1 (fr)	2007-03-07
EP1758914B1 (fr)	2007-11-21
NZ551948A (en)	2010-04-30

Publication	Publication Date	Title
HRPK20041201B3 (en)	2006-12-31	Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
IL193834A0 (en)	2009-08-03	Antibacterial agents
HRPK20040930B3 (en)	2006-09-30	Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
CY1122863T1 (el)	2020-11-25	Φαρμακευτικη συνθεση που περιεχει γλυκοπυρρολικο και εναν αγωνιστη βητα2 αδρενοϋποδοχεα
HRP20010484B1 (hr)	2010-08-31	Supstituirani benzimidazoli, njihovo pripravljanje i korištenje
CO5601014A2 (es)	2006-01-31	Nuevos compuestos heterociclicos, activos como inhibidores de beta-lactamasas
ATE506354T1 (de)	2011-05-15	Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
HUP0300382A2 (hu)	2003-06-28	2-Szubsztituált-4-heteroaril-pirimidinek és alkalmazásuk proliferatív rendellenességek kezelésében és a vegyületeket tartalmazó gyógyszerkészítmények
DE69820614D1 (de)	2004-01-29	Entzündungshemmende tyrosin-derivate
DE60335359D1 (de)	2011-01-27	Phthalazinonderivate
TR200402069T4 (tr)	2004-09-21	Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması
AR039689A1 (es)	2005-03-09	Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
ATE385234T1 (de)	2008-02-15	Sulfonamidsubstituierte xanthinderivate zur verwendung als pepck-inhibitoren
CY1110145T1 (el)	2015-01-14	Αλκυλο-υποκατεστημενες ινδολοκινοξαλινες
HRPK20041161B3 (en)	2006-09-30	N-benzoylureidocinnamate derivatives, method for production and use thereof
DE60327922D1 (de)	2009-07-23	Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren
PT1021405E (pt)	2003-02-28	Derivados de azetidinona para o tratamento de infeccoes de hcmv
CO4810374A1 (es)	1999-06-30	Nueva utilizacion de compuestos para actividad anti- pruritica
CO5160261A1 (es)	2002-05-30	Derivados de bifenilo sustituidos que son antagonistas nk-1, su procedimiento de sintesis y composiciones farmaceuticas que los contienen
HRP20030713B1 (en)	2006-02-28	Imidazolidine derivatives their preparation, and their use as antiflamatory agent
DK0934278T3 (da)	2003-01-06	Bis(acridincarboxamid) og bis(phenazincarboxamid) som antitumormidler
DE50212907D1 (de)	2008-11-27	Neue azopigmente
DE59802149D1 (de)	2001-12-20	Fungizide mischungen
GB0307855D0 (en)	2003-05-14	Organic compounds
CY1105373T1 (el)	2010-04-28	Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα